## Abstract ## Background The role of radiofrequency ablation (RFA) for perivascular (up to 5 mm from the major intrahepatic portal vein or hepatic vein branches) hepatocellular carcinoma (HCC) is unclear because of possible incomplete tumour ablation and potential vascular damage. This study aime
Laparoscopic-assisted microwave ablation for hepatocellular carcinoma: Safety and efficacy in comparison with radiofrequency ablation
β Scribed by Kerri A. Simo; Stephanie E. Sereika; Kimberly N. Newton; David A. Gerber
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 211 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Radiofrequency ablation (RFA) for patients with hepatocellular carcinoma (HCC) has been reported previously. This technique is superior to percutaneous microwave coagulation therapy (PMCT) for the enlargement of the necrotic area. Therefore, a few treatment sessions of RFA for patie
## Background: The therapeutic efficacy of radiofrequency ablation (rfa) for hepatocellular carcinoma (hcc) is limited by the small volume of coagulation necrosis obtained at each activation of the rf system and the sometimes irregular burn shape due to the proximity of large vessels that have a co
## Abstract ## BACKGROUND: Radiofrequency ablation (RFA) is becoming a wellβknown local therapy for hepatocellular carcinoma (HCC). Transcatheter arterial chemoembolization (TACE) is expected to enhance the effects of subsequent RFA by reducing arterial blood flow. However, the longβterm efficacy